Yamada Takayuki, Ueyama Hiroki, Chopra Nitin, Yamaji Takahiro, Azushima Kengo, Kobayashi Ryu, Kinguchi Sho, Urate Shingo, Suzuki Toru, Abe Eriko, Saigusa Yusuke, Wakui Hiromichi, Partridge Paulina, Burger Alfred, Bravo Claudio A, Rodriguez Maria A, Ivey-Miranda Juan, Tamura Kouichi, Testani Jeffery, Coca Steven
Department of Medicine, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Kidney Int Rep. 2020 Jul 2;5(9):1486-1494. doi: 10.1016/j.ekir.2020.06.031. eCollection 2020 Sep.
Outcomes in acute decompensated heart failure (ADHF) have remained poor. Worsening renal function (WRF) is common among patients with ADHF. However, the impact of WRF on the prognosis is controversial. We hypothesized that in patients with ADHF, the achievement of concomitant decongestion would diminish the signal for harm associated with WRF.
We performed a systematic search of PubMed, EMBASE, and the Cochrane Library up to December 2019 for studies that assessed signs of decongestion in patients with WRF during ADHF admission. The primary outcome was all-cause mortality and heart transplantation.
Thirteen studies were selected with a pooled population of 8138 patients. During the follow-up period of 60-450 days, 19.2% of patients died. Unstratified, patients with WRF versus no WRF had a higher risk for mortality (odds ratio [OR], 1.71 [95% confidence interval {CI}, 1.45-2.01]; < 0.0001). However, patients who achieved decongestion had a similar prognosis (OR, 1.15 [95% CI, 0.89-1.49]; = 0.30). Moreover, patients with WRF who achieved decongestion had a better prognosis compared with those without WRF or decongestion (OR, 0.63 [95% CI, 0.46-0.86]; = 0.004). This tendency persisted for the sensitivity analyses.
Decongestion is a powerful effect modifier that attenuates harmful associations of WRF with mortality. Future studies should not assess WRF as an endpoint without concomitant assessment of achieved volume status.
急性失代偿性心力衰竭(ADHF)的预后一直很差。肾功能恶化(WRF)在ADHF患者中很常见。然而,WRF对预后的影响存在争议。我们假设,在ADHF患者中,实现同时性消肿将减少与WRF相关的不良信号。
我们对截至2019年12月的PubMed、EMBASE和Cochrane图书馆进行了系统检索,以查找评估ADHF住院期间WRF患者消肿迹象的研究。主要结局是全因死亡率和心脏移植。
选取了13项研究,汇总人群为8138例患者。在60 - 450天的随访期内,19.2%的患者死亡。未分层时,有WRF的患者与无WRF的患者相比,死亡风险更高(比值比[OR],1.71[95%置信区间{CI},1.45 - 2.01];P < 0.0001)。然而,实现消肿的患者预后相似(OR,1.15[95% CI,0.89 - 1.49];P = 0.30)。此外,实现消肿的WRF患者与未实现消肿或无WRF的患者相比,预后更好(OR,0.63[95% CI,0.46 - 0.86];P = 0.004)。这种趋势在敏感性分析中持续存在。
消肿是一种强大的效应修饰因素,可减弱WRF与死亡率之间的有害关联。未来的研究在不同时评估已实现的容量状态的情况下,不应将WRF作为一个终点来评估。